BRG1 and prohibitin (PHB) are essential for androgen antagonist-mediated repression in prostate cancer [119], while PHB-SWI/SNF interactions aid estrogen antagonist-induced growth suppression in breast cancer [75]. The gene discussed is PHB1; the disease is prostate carcinoma.